Albemarle said net sales for Q2 2025 were $1.3 billion, with total sales volumes growing 9% year-over-year and Energy Storage volumes growing 15%. The company cited lower lithium carbonate and hydroxide market pricing, which decreased net sales by $233.4 million, and higher sales volumes, which increased net sales by $129.1 million, as factors in the net sales change.

1. 01

   Albemarle said net sales for Q2 2025 were $1.3 billion, with total sales volumes growing 9% year-over-year and Energy Storage volumes growing 15%. The company cited lower lithium carbonate and hydroxide market pricing, which decreased net sales by $233.4 million, and higher sales volumes, which increased net sales by $129.1 million, as factors in the net sales change.

2. 02

   In June 2025, Albemarle agreed to redeem the preferred equity of a Grace subsidiary for an aggregate value of $307.4 million, comprised of $288.0 million in cash received in June 2025 for the redemption and $19.4 million in cash previously received for tax liabilities. The company recorded a loss of $38.0 million, the difference between the fair value of the preferred equity prior to redemption of $326.0 million and the cash received.

3. 03

   Albemarle said cash flows from operations for the first six months of 2025 were $538.2 million, an increase from $465.1 million in the prior year. The company cited customer advance payments of $350 million as a factor in the change and said it used cash for capital expenditures of $302.3 million, common share dividends of $95.2 million and convertible preferred stock dividends of $83.4 million.

4. 04

   Albemarle disclosed restructuring actions including the suspension of construction of Kemerton Trains 3 and 4, the transition of Kemerton Train 2 and the Chengdu conversion facility to care and maintenance, and said it recorded asset write-offs of $1.0 billion since the inception of the plan. The company said it expects capital expenditures for 2025 to be $650 million to $700 million.

Key figures

Quarter ended June 30, 2025

Revenue

$1.3B

Operating income

$48M

Net income

$23M

EPS

−$0.16

Gross profit

$197M

Operating cash flow

$547M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.